POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug may help PMR patients ditch steroids faster
Disease control CompletedThis study tested a drug called secukinumab in 381 adults with polymyalgia rheumatica (PMR), a condition causing pain and stiffness. Participants received either secukinumab or a placebo, along with a steroid taper over 24 weeks. The goal was to see if secukinumab could help more…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:28 UTC
-
New IV drug shows promise for inflammatory conditions in early trial
Disease control CompletedThis early-stage study tested an intravenous (IV) form of secukinumab in 65 adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR), two inflammatory conditions. The goal was to see how the drug moves through the body and whether it is safe. Participants received m…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC